Abstract:OBJECTIVE:To investigate combined chemotherapeutic effects of rofecoxib in combination with 5-fluorouracil (5-FU), cisplatin (DDP) and etoposide (VP-16) in vitro, and to explore the potential mechanisms in modulating multidrug resistance (MDR) expression.MEHTODS:The BGC-823 gastric cancer cell line was incubated for 48 h with 0.1 mu mol/L rofecoxib, 5-FU, DDP and VP-16 (1 mu g/mL, 10 mu g/mL and 100 mu g/mL) alone, and combined with rofecoxib, respectively. Methyl-thiazolyl-tetrazolium and the terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-yriphosphate nick-end labeling assays were performed to calculate inhibitory rates and apoptotic index. Middle effects principles (CI values) were used to determine the interaction between rofecoxib and chemotherapeutic agents. Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis were employed to determine expression of MDR1, multidrug resistance-associated protein 1 (MRP1), glutathione S-tranferase-pi (GST-pi) mRNA and protein in gastric cancer cells administered by rofecoxib, respectively.RESULTS:Both anticancer drugs such as 5-FU, DDP and VP-16 and rofecoxib inhibited the cells' proliferation and induced apoptosis in a dose-dependent manner, and a more significant inhibition was achieved when the cells were co-treated with anticancer drugs and rofecoxib. There was a synergetic role when different concentrations of chemotherapeutic agents were combined with rofecoxib (all CI < 1, P < 0.01 or 0.05). RT-PCR analyses of MDR gene families in BGC-823 gastric cancer cells revealed a strong expression in MRP1 and GST-pi mRNA, but MDR1 mRNA was undetectable. After administration with different concentrations of rofecoxib (0.1, 1.0, 10 mu mol/L), significant downregulation of MRP1 and GST-pi mRNA was observed (MRP1: from 0.984 +/- 0.093-0.513 +/- 0.098; GST-pi: from 1.078 +/- 0.201-0.472 +/- 0.084, P < 0.01 or 0.05). In addition, MRP1 and GST-pi protein expression induced by rofecoxib were also reduced (P < 0.01 or 0.05).CONCLUSION:Rofecoxib, a specific cyclooxygenase-2 inhibitor, plays a chemotherapeutic sensitizer role in various anticancer agents on the BGC-823 gastric cancer cell line, which could be partly explained by its ability to reverse the intrinsic MRP1 and GST-pi in vitro.

Guggulsterone Sensitized Drug-Resistant Human Hepatocarcinoma Cells to Doxorubicin Through a Cox-2/P-gp Dependent Pathway.

Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.

N1-guanyl-1,7-diaminoheptane (GC7) Enhances the Therapeutic Efficacy of Doxorubicin by Inhibiting Activation of Eukaryotic Translation Initiation Factor 5A2 (eif5a2) and Preventing the Epithelial–mesenchymal Transition in Hepatocellular Carcinoma Cells

Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo

Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines.

Reversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell lines.

Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein

Cryptotanshinone Potentiates the Antitumor Effects of Doxorubicin on Gastric Cancer Cells Via Inhibition of STAT3 Activity.

Guggulsterone Induces Apoptosis of Human Hepatocellular Carcinoma Cells Through Intrinsic Mitochondrial Pathway

Guggulsterone Inhibits Human Cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 Cell Growth by Inducing Caspase-Dependent Apoptosis and Downregulation of Survivin and Bcl-2 Expression.

Guggulsterone Regulates the Function and Expression of P-glycoprotein in Rat Brain Microvessel Endothelial Cells.

Rofecoxib Augments Anticancer Effects by Reversing Intrinsic Multidrug Resistance Gene Expression in Bgc-823 Gastric Cancer Cells

Z-Guggulsterone Inhibits Tumor Cell Proliferation, Migration in Vitro and Tumor Growth in Vivo Through PTEN/Akt/COX-2 Signaling Pathway

Inhibition of the P38 Mapk Pathway Sensitizes Human Gastric Cells to Doxorubicin Treatment in Vitro and in Vivo

Retracted: Guggulsterone Inhibits Prostate Cancer Growth Via Inactivation of Akt Regulated by ATP Citrate Lyase Signaling.

Guggulsterone from Commiphora Mukul Potentiates Anti-Glioblastoma Efficacy of Temozolomide in Vitro and in Vivo Via Down-Regulating EGFR/PI3K/Akt Signaling and NF-κB Activation.

Protection Against Hydrogen Peroxide-Induced Cytotoxicity in PC12 Cells by Guggulsterone.

Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.

Inhibition of P38 MAPK Diminishes Doxorubicin-Induced Drug Resistance Associated with P-glycoprotein in Human Leukemia K562 Cells

Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?

Z-Guggulsterone Induces Apoptosis in Gastric Cancer Cells through the Intrinsic Mitochondria-Dependent Pathway